title: Erythema multiforme due to pyrazinamide.
abstract: Drug-induced erythema multiforme is reported with many antimicrobial and antipyretic medications. We present one patient who experienced erythema multiforme and urticaria after administration of pyrazinamide for treatment of cutaneous tuberculosis. The side-effects of pyrazinamide include hepatic or dermatologic disorders, but erythema multiforme has not yet, to our knowledge, been described. Clinical features and discontinuation and reintroduction of the drug led us to consider pyrazinamide the cause of the erythema multiforme, but allergologic studies remained negative, except for the presence of circulating immune complexes. The mechanism of this eruption remains obscure, and definite withdrawal of pyrazinamide seems to be the best therapeutic choice.
authors.affiliation: Department of Respiratory Diseases and Allergology, University Hospital of Reims, France.
authors.forename: D
authors.initials: D
authors.lastname: Perdu
authors.forename: F
authors.initials: F
authors.lastname: Lavaud
authors.forename: A
authors.initials: A
authors.lastname: Prévost
authors.forename: F
authors.initials: F
authors.lastname: Deschamps
authors.forename: M P
authors.initials: MP
authors.lastname: Cambie
authors.forename: E
authors.initials: E
authors.lastname: Bongrain
authors.forename: K
authors.initials: K
authors.lastname: Barhoum
authors.forename: B
authors.initials: B
authors.lastname: Kalis
mesh_terms: D000368:Aged; D000995:Antitubercular Agents / Q000009:adverse effects; D004892:Erythema Multiforme / Q000139:chemically induced*; D006801:Humans; D008297:Male; D011718:Pyrazinamide / Q000009:adverse effects*
chemical_list: D000995:Antitubercular Agents; D011718:Pyrazinamide